AUSTIN (KXAN) — Austin physicians are trying new ways to treat chronic heart conditions. Five cardiologists at Heart Hospital of Austin are the first in the nation to administer a valve replacement ...
Abbott (NYSE: ABT) + reported new study findings supporting the use of its Tendyne transcatheter mitral valve replacement (TMVR) system. Tendyne offers an option for patients with mitral valves that ...
SAN FRANCISCO, CA—Transcatheter mitral valve replacement (TMVR) with the Tendyne system (Abbott) successfully treats mitral regurgitation (MR) or stenosis complicated by severe mitral annular ...
SAN FRANCISCO, Oct. 8, 2025 /PRNewswire/ -- Bunkerhill Health today announced that it has received U.S. Food and Drug Administration (FDA) clearance for Bunkerhill MAC, the first artificial ...
Mitral annular calcification (MAC) is common in the setting of chronic kidney disease and aging. Previously presumed "degenerative" in etiology, cardiac/vascular calcification is now understood to be ...
Patients with heart failure and atrial fibrillation (AF) at the time of mitral transcatheter edge-to-edge repair (M-TEER) for severe mitral regurgitation are more than twice as likely to die or be ...
The authors have declared no conflicts of interest. Pre- and post-procedural transthoracic and procedural transoesophageal echocardiographic studies of 25 patients treated at University Heart Center ...
Please provide your email address to receive an email when new articles are posted on . A transcatheter mitral valve replacement system was approved for patients at high surgical risk. The system is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results